InsiderFlow

Harrow Health, Inc.

$34.22-1.34 (-3.77%)

Prev Close

$35.56

Open

$35.80

High

$36.15

Low

$33.74

Volume

909.2K

Market Cap

$1.31B

P/E

Div Yield

Over the past 12 months, insider activity at Harrow Health, Inc. (HROW) has been exclusively selling, with 0 insider purchases totaling $0.00 and 9 insider sales totaling $46.29M. The most recent insider transaction was by Opaleye Management Inc. (10 percent owner), who sold $15.69M worth of shares on Mar 5, 2026. Harrow Health, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $1.31B.

Buys (12M)

0

$0.00

Sells (12M)

9

$46.29M

Net Activity

Net Seller

$46.29M

Active Insiders

4

last 12 mo

HROW Price Chart

HROW Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 5, 2026Opaleye Management Inc.10 percent ownerSell397,144$39.51$15.69M3,756,000
Mar 3, 2026Opaleye Management Inc.10 percent ownerSell5,000$54.18$270.9K65,000
Jan 8, 2026Opaleye Management Inc.10 percent ownerSell20,000$53.35$1.07M70,000
Dec 12, 2025BAUM MARK LCHIEF EXECUTIVE OFFICERSell79,994$47.06$3.76M0
Dec 12, 2025BOLL ANDREW R.PRESIDENT AND CFOSell26,665$47.06$1.25M0
Jul 21, 2025BAUM MARK LCHIEF EXECUTIVE OFFICERSell313,338$37.08$11.62M0
Apr 3, 2025BAUM MARK LChief Executive OfficerSell300,363$23.09$6.94M0
Apr 3, 2025BOLL ANDREW R.Chief Financial OfficerSell136,745$23.09$3.16M0
Apr 3, 2025SAHAREK JOHN P.CEO & President, ImprimisRxSell109,475$23.09$2.53M0
Jan 24, 2025Opaleye Management Inc.10% OwnerSell20,000$35.59$711.8K155,000

HROW Insider Buying Activity

The following table shows recent insider purchases of Harrow Health, Inc. (HROW) stock reported via SEC Form 4 filings.

No insider buying activity found for HROW in the last 12 months.

HROW Insider Selling Activity

The following table shows recent insider sales of Harrow Health, Inc. (HROW) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Mar 5, 2026Opaleye Management Inc.10 percent ownerSell397,144$39.51$15.69M3,756,000
Mar 3, 2026Opaleye Management Inc.10 percent ownerSell5,000$54.18$270.9K65,000
Jan 8, 2026Opaleye Management Inc.10 percent ownerSell20,000$53.35$1.07M70,000
Dec 12, 2025BAUM MARK LCHIEF EXECUTIVE OFFICERSell79,994$47.06$3.76M0
Dec 12, 2025BOLL ANDREW R.PRESIDENT AND CFOSell26,665$47.06$1.25M0
Jul 21, 2025BAUM MARK LCHIEF EXECUTIVE OFFICERSell313,338$37.08$11.62M0
Apr 3, 2025BAUM MARK LChief Executive OfficerSell300,363$23.09$6.94M0
Apr 3, 2025BOLL ANDREW R.Chief Financial OfficerSell136,745$23.09$3.16M0
Apr 3, 2025SAHAREK JOHN P.CEO & President, ImprimisRxSell109,475$23.09$2.53M0
Jan 24, 2025Opaleye Management Inc.10% OwnerSell20,000$35.59$711.8K155,000

HROW Insiders

Opaleye Management Inc.

10 percent owner

Sold $17.03M
10 tradesLast: Mar 4, 2026
BAUM MARK L

CHIEF EXECUTIVE OFFICER

Sold $15.38M
2 tradesLast: Dec 12, 2025
BOLL ANDREW R.

PRESIDENT AND CFO

Sold $1.25M
1 tradesLast: Dec 12, 2025
BAUM MARK L

Chief Executive Officer

Sold $6.94M
1 tradesLast: Apr 7, 2025
BOLL ANDREW R.

Chief Financial Officer

Sold $3.16M
1 tradesLast: Apr 7, 2025
SAHAREK JOHN P.

CEO & President, ImprimisRx

Sold $2.53M
1 tradesLast: Apr 7, 2025
Opaleye Management Inc.

10% Owner

Sold $711.8K
1 tradesLast: Jan 22, 2025